|
1
|
Villanueva A: Hepatocellular carcinoma. N
Engl J Med. 380:1450–1462. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Matsushita H and Takaki A: Alcohol and
hepatocellular carcinoma. BMJ Open Gastroenterol. 6:e0002602019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Petrick JL, Kelly SP, Altekruse SF,
McGlynn KA and Rosenberg PS: Future of hepatocellular carcinoma
incidence in the United States forecast through 2030. J Clin Oncol.
34:1787–1794. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zucman-Rossi J, Villanueva A, Nault JC and
Llovet JM: Genetic landscape and biomarkers of hepatocellular
carcinoma. Gastroenterology. 149:1226–1239 e1224. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Levrero M and Zucman-Rossi J: Mechanisms
of HBV-induced hepatocellular carcinoma. J Hepatol. 64 (1
Suppl):S84–S101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Louafi S, Boige V, Ducreux M, Bonyhay L,
Mansourbakht T, de Baere T, Asnacios A, Hannoun L, Poynard T and
Taïeb J: Gemcitabine plus oxaliplatin (GEMOX) in patients with
advanced hepatocellular carcinoma (HCC): Results of a phase II
study. Cancer. 109:1384–1390. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hung T and Chang HY: Long noncoding RNA in
genome regulation: Prospects and mechanisms. RNA Biol. 7:582–585.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv
XW and Li J: Long noncoding RNAs: Novel insights into hepatocelluar
carcinoma. Cancer Lett. 344:20–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheetham SW, Gruhl F, Mattick JS and
Dinger ME: Long noncoding RNAs and the genetics of cancer. Br J
Cancer. 108:2419–2425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hauptman N and Glavac D: Long non-coding
RNA in cancer. Int J Mol Sci. 14:4655–4669. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang Z, Zhou L, Wu LM, Lai MC, Xie HY,
Zhang F and Zheng SS: Overexpression of long non-coding RNA HOTAIR
predicts tumor recurrence in hepatocellular carcinoma patients
following liver transplantation. Ann Surg Oncol. 18:1243–1250.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Geng YJ, Xie SL, Li Q, Ma J and Wang GY:
Large intervening non-coding RNA HOTAIR is associated with
hepatocellular carcinoma progression. J Int Med Res. 39:2119–2128.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang L, Peng X, Li Y, Zhang X, Ma Y, Wu C,
Fan Q, Wei S, Li H and Liu J: Long non-coding RNA HOTAIR promotes
exosome secretion by regulating RAB35 and SNAP23 in hepatocellular
carcinoma. Mol Cancer. 18:782019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim KS and Lee YI: Biallelic expression of
the HI9 and ZGF2 genes in hepatocellular carcinoma. Cancer Lett.
119:143–148. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu XT, Yuan JH, Zhu TT, Li YY and Cheng
XY: Long noncoding RNA glypican 3 (GPC3) antisense transcript 1
promotes hepatocellular carcinoma progression via epigenetically
activating GPC3. FEBS J. 283:3739–3754. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ganne-Carrie N and Nahon P: Hepatocellular
carcinoma in the setting of alcohol-related liver disease. J
Hepatol. 70:284–293. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pimpin L, Cortez-Pinto H, Negro F,
Corbould E, Lazarus JV, Webber L and Sheron N; EASL HEPAHEALTH
Steering Committee, : Burden of liver disease in Europe:
Epidemiology and analysis of risk factors to identify prevention
policies. J Hepatol. 69:718–735. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bucci L, Garuti F, Camelli V, Lenzi B,
Farinati F, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di
Marco M, et al: Comparison between alcohol- and hepatitis C
virus-related hepatocellular carcinoma: Clinical presentation,
treatment and outcome. Aliment Pharmacol Ther. 43:385–399. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Heagerty PJ, Lumley T and Pepe MS:
Time-dependent ROC curves for censored survival data and a
diagnostic marker. Biometrics. 56:337–344. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Budhu A, Forgues M, Ye QH, Jia HL, He P,
Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY and Wang XW:
Prediction of venous metastases, recurrence, and prognosis in
hepatocellular carcinoma based on a unique immune response
signature of the liver microenvironment. Cancer Cell. 10:99–111.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin Y, Liang R, Qiu Y, Lv Y, Zhang J, Qin
G, Yuan C, Liu Z, Li Y, Zou D and Mao Y: Expression and gene
regulation network of RBM8A in hepatocellular carcinoma based on
data mining. Aging (Albany NY). 11:423–447. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu Y, Zheng S, Yao J, Li M, Yang G, Zhang
N, Zhang S and Zhong B: Decreased expression of protocadherin 20 is
associated with poor prognosis in hepatocellular carcinoma.
Oncotarget. 8:3018–3028. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang X, Xie X, Xiao YF, Xie R, Hu CJ, Tang
B, Li BS and Yang SM: The emergence of long non-coding RNAs in the
tumorigenesis of hepatocellular carcinoma. Cancer Lett.
360:119–124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiong H, Li B, He J, Zeng Y, Zhang Y and
He F: lncRNA HULC promotes the growth of hepatocellular carcinoma
cells via stabilizing COX-2 protein. Biochem Biophys Res Commun.
490:693–699. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Z, Li J, He T, Ouyang Y, Huang Y,
Liu Q, Wang P and Ding J: The competitive endogenous RNA regulatory
network reveals potential prognostic biomarkers for overall
survival in hepatocellular carcinoma. Cancer Sci. 110:2905–2923.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin P, Wen DY, Li Q, He Y, Yang H and Chen
G: Genome-wide analysis of prognostic lncRNAs, miRNAs, and mRNAs
forming a competing endogenous RNA network in hepatocellular
carcinoma. Cell Physiol Biochem. 48:1953–1967. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qin Z, Wang Y, Tang J, Zhang L, Li R, Xue
J, Han P, Wang W, Qin C, Xing Q, et al: High LINC01605 expression
predicts poor prognosis and promotes tumor progression via
up-regulation of MMP9 in bladder cancer. Biosci Rep.
38:BSR201805622018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang S, Cao R, Li Q, Yao M, Chen Y and
Zhou H: Comprehensive analysis of lncRNA-associated competing
endogenous RNA network in tongue squamous cell carcinoma. PeerJ.
7:e63972019. View Article : Google Scholar : PubMed/NCBI
|
